Heron Therapeutics
HRTX
#8198
Rank
NZ$0.42 B
Marketcap
NZ$2.34
Share price
1.88%
Change (1 day)
-21.62%
Change (1 year)

Heron Therapeutics (HRTX) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$0.43 Billion

According to Heron Therapeutics's latest financial reports the company's total assets are NZ$0.43 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Heron Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$0.41 B17.5%
2023-12-31NZ$0.35 B-10.98%
2022-12-31NZ$0.39 B-11.69%
2021-12-31NZ$0.44 B-8.66%
2020-12-31NZ$0.49 B-35.64%
2019-12-31NZ$0.76 B10.5%
2018-12-31NZ$0.68 B108.85%
2017-12-31NZ$0.32 B238.65%
2016-12-31NZ$97.42 M-51.63%
2015-12-31NZ$0.20 B105.79%
2014-12-31NZ$97.86 M5.91%
2013-12-31NZ$92.4 M35.81%
2012-12-31NZ$68.03 M173.09%
2011-12-31NZ$24.91 M560.3%
2010-12-31NZ$3.77 M-69.38%
2009-12-31NZ$12.32 M-39.39%
2008-12-31NZ$20.33 M-57.85%
2007-12-31NZ$48.23 M97%
2006-12-31NZ$24.48 M86.61%
2005-12-31NZ$13.12 M-44.97%
2004-12-31NZ$23.84 M17.82%
2003-12-31NZ$20.23 M-40.44%
2002-12-31NZ$33.97 M-39.98%
2001-12-31NZ$56.6 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Alkermes
ALKS
NZ$4.02 B 835.73%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Pacira Biosciences
PCRX
NZ$2.24 B 421.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ$0.52 B 21.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$2.55 B 493.20%๐Ÿ‡บ๐Ÿ‡ธ USA
SurModics
SRDX
NZ$0.29 B-31.78%๐Ÿ‡บ๐Ÿ‡ธ USA